Mayo joins network to improve access to clinical trials
Volume 7, Issue 3, 2018
A partnership for the Cancer Center and Mayo Clinic Health System reduces travel burdens for patients.
Stephan D. Thome, M.D.
Sumit Bhagra, M.D.
Charles L. Loprinzi, M.D.
The Mayo Clinic Cancer Center and Mayo Clinic Health System are participating in a new statewide clinical trials network aimed at improving access to new cancer treatments and enhanced care delivery.
The Minnesota Cancer Clinical Trials Network leverages clinical trials originating from Minnesota's two National Cancer Institute-designated Comprehensive Cancer Centers — the Mayo Clinic Cancer Center and the Masonic Cancer Center at the University of Minnesota — along with the Hormel Institute in Austin, Minnesota.
"The Minnesota Cancer Clinical Trials Network brings National Cancer Institute group trials, as well as trials initiated by Mayo Clinic, the University of Minnesota and the Hormel Institute, to our patients, closer to where they live," said Stephan D. Thome, M.D., a hematologist-oncologist and the regional medical director of oncology for Mayo Clinic Health System in Mankato, Minnesota. "Individuals facing a cancer diagnosis often travel long distances to gain access to clinical trials. This program and partnership allows Mayo Clinic Health System in Mankato to help reduce some of the extra burden of travel on our patients and offers new opportunities for hope and healing locally."
"Clinical trials help discover better ways to prevent, diagnose and treat cancer," said Sumit Bhagra, M.D., an endocrinologist and the medical director for Mayo Clinic Health System in Albert Lea and Austin, Minnesota. "When facing a cancer diagnosis, it makes a big difference to patients to get care close to home. Our patients will now have the opportunity to access clinical trials without needing to travel long distances."
Charles L. Loprinzi, M.D., an oncologist at Mayo Clinic in Rochester, Minnesota, is the medical director for the Minnesota Cancer Clinical Trials Network.